ENTITY
Kolon Life Science

Kolon Life Science (102940 KS)

14
Analysis
Health Care • South Korea
Kolon Life Science., Inc. develops, manufactures, and sells Pharmaceutical Ingredients, Specialty Chemicals, Biotechnology, and Biological New Drugs. The Company's main products are anti-inflammatory drugs, drugs for the circulatory system, digestive & urinary system, antibiotics, etc.
more
•07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.6k Views
Share
•05 Jul 2016 09:24

What the IPOs Completed in Korea Stock Exchange in 1H 2016 Reveal....

If you want to outperform the market, perhaps you should take a look at the IPO market in Korea. In the midst of difficult global IPO markets, the...

Logo
416 Views
Share
•16 Feb 2016 00:59

2016 Major IPOs Pipeline in Korea - Part II

In our previous report - 2016 Major IPOs Pipeline in Korea, we identified 19 companies that are seeking to complete IPOs in Korea in 2016. In this...

Logo
353 Views
Share
•12 Feb 2016 23:11

2016 Major IPOs Pipeline in Korea

This year appears to be an exciting year for IPOs in Korea, barring a dramatic downturn in global equities markets like the one we experienced in...

Logo
375 Views
Share
x